A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usual (TAU)

被引：0
|
作者：
Chue, P. [1 ]
Silverstone, P. [1 ]
Hillier, T. [1 ]
Rizvi, S. [1 ]
Phillips, S. [1 ]
Langkaas, L. -A. [1 ]
Davidson, K. [2 ]
Brown, M. [2 ]
Chue, J. [3 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Zylorion, Edmonton, AB, Canada
[3] Amygdala Associates, Edmonton, AB, Canada
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
10.1192/j.eurpsy.2023.903
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0604
引用
收藏
页码：S419 / S420
页数：2
相关论文
共 6 条
  • [1] A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usual (TAU)
    Chue, P.
    Silverstone, P.
    Hillier, T.
    Rizvi, S.
    Phillips, S.
    Langkaas, L. -A
    Davidson, K.
    Brown, M.
    Chue, J.
    EUROPEAN PSYCHIATRY, 2023, 66 : S419 - S420
  • [2] S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study
    De Berardis, Domenico
    Marini, Stefano
    Serroni, Nicola
    Rapini, Gabriella
    Iasevoli, Felice
    Valchera, Alessandro
    Signorelli, Maria
    Aguglia, Eugenio
    Perna, Giampaolo
    Salone, Anatolia
    Di Iorio, Giuseppe
    Martinotti, Giovanni
    Di Giannantonio, Andmassimo
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [3] Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study
    Nagahide Takahashi
    Aya Yamada
    Ayako Shiraishi
    Hiroko Shimizu
    Ryosuke Goto
    Yushin Tominaga
    BMC Psychiatry, 21
  • [4] Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study
    Takahashi, Nagahide
    Yamada, Aya
    Shiraishi, Ayako
    Shimizu, Hiroko
    Goto, Ryosuke
    Tominaga, Yushin
    BMC PSYCHIATRY, 2021, 21 (01)
  • [5] Design and rationale of the REStoring mood after early life trauma with psychotherapy (RESET-psychotherapy) study: a multicenter randomized controlled trial on the efficacy of adjunctive trauma-focused therapy (TFT) versus treatment as usual (TAU) for adult patients with major depressive disorder (MDD) and childhood trauma
    Gathier, Anouk W.
    Verhoeven, Josine E.
    van Oppen, Patricia C.
    Penninx, Brenda W. J. H.
    Merkx, Maarten J. M.
    Dingemanse, Pieter
    Stehouwer, Kim M. K. S.
    van den Bulck, Carmen M. M.
    Vinkers, Christiaan H.
    BMC PSYCHIATRY, 2023, 23 (01)
  • [6] Design and rationale of the REStoring mood after early life trauma with psychotherapy (RESET-psychotherapy) study: a multicenter randomized controlled trial on the efficacy of adjunctive trauma-focused therapy (TFT) versus treatment as usual (TAU) for adult patients with major depressive disorder (MDD) and childhood trauma
    Anouk W. Gathier
    Josine E. Verhoeven
    Patricia C. van Oppen
    Brenda W. J. H. Penninx
    Maarten J. M. Merkx
    Pieter Dingemanse
    Kim M. K. S. Stehouwer
    Carmen M. M. van den Bulck
    Christiaan H. Vinkers
    BMC Psychiatry, 23
1